Park Jae-Pyeong

Senior Managing Director

Jaepyung Park

Senior Managing Director

15 past transactions

Style Recipe

Seed Round in 2023
Style Recipe is a fashion curation platform that offers customized fashion.

Livfarm

Seed Round in 2022
Livfarm is an online platform that specializes in the delivery of fresh vegetables and salad samplers. The company cultivates its produce in urban areas, ensuring that the vegetables are harvested and delivered immediately upon order to maintain freshness. Livfarm also utilizes indoor cultivation UV technologies, which further enhances the quality of their produce. In addition, the company offers a customized menu, allowing customers to select their preferred vegetables. Livfarm is revolutionizing the way lettuce reaches the table through its fully automated hydroponic solution, which enables the company to grow lettuce near the delivery point.

Vibezone

Venture Round in 2022
Vibezone is a fanbase-oriented K-pop vibe platform that proposes K-pop fanbase services and products.

GeoAT

Seed Round in 2022
GeoAT app enables people to buy home appliances by comparing prices.

Pampam

Series A in 2022
Pampam is a luxury goods trading platform.

Etnova Therapeutics

Series A in 2022
Etnova Therapeutics is a bio-venture company that specializes in the research and development of new drug substances.

Polaris3D

Venture Round in 2022
Polaris3d offers indoor autonomous navigating solution.

Travel C2B

Seed Round in 2021
Travel C2B is a search engine that provides travel information services.

Plant Hall

Seed Round in 2021
Plant Hall is a landscaping company that offers plant sales and rental services.

HayanMind Inc.

Seed Round in 2020
HayanMind provides language-learning services. They help people learn different languages, enabling them to look at everything with a clean, pure mind and without prejudice.

Thyroscope

Seed Round in 2020
Thyroscope wearable device analysis thyroid risk levels from body bio-signals and offers real-time updates without blood tests.

Mediwhale

Seed Round in 2020
Medi Whale seeks to achieve sustainable healthcare where every eye can truly be the window to one’s health with our world's first-of-its-kind 1-stop AI screening platform solution for cardiovascular, renal, metabolic risk assessment, and eye disease diagnosis. Our AI Platform was developed through several clinical collaborations (Korea, Singapore, India, UK, and other European datasets) using structured longitudinal event-based datasets for the development of our retinal biomarker engines. RetiCVD® (cardiovascular disease risk assessment): Developed using coronary artery calcium (CAC) score, CAC is recognized as the gold standard for precise CVD risk calculation. Our CVD engine predicts the presence of CAC and provides a stratified probabilistic risk based on US ASCVD and EU SCORE guidelines. RetiCKD® (chronic kidney disease risk assessment): Developed using eGFR and full lab panel, our CKD engine has been demonstrated to achieve better predictive capability as compared to eGFR or full panel analysis. RetiEYE®: Referable Eye Disease engine detects and flags common aging-related eye modalities such as diabetic retinopathy, age-related macular degeneration, glaucoma, and cataract at its referable disease state. Medi Whale retinal-based systemic biomarkers have been clinically demonstrated to be non-inferior to current gold standards and are recognized by clinical and scientific communities with two Lancet Digital Health publications.

Solomonster

Seed Round in 2020
Advertising agency, digital content development, supply, pop culture art planning/e-commerce

NYX

Seed Round in 2020
NYX Inc. develops gosleep that manages the entire sleep cycle from sleeping to waking with a function that users can feel.

ited

Seed Round in 2019
ited supplies transparent heating film and glasses for the automotive industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.